Transforming cancer treatment for greatest impact
Drug Target Review
JANUARY 15, 2024
Could you provide insights into the driving factors behind exploring novel treatments for cancer types? Based on this rationale we selected skin cancer, triple-negative breast cancer, and head and neck cancers as our initial indications for our Phase 1 trials. What aspects prompted this research direction?
Let's personalize your content